Sellas presses ahead with fast track designation for lymphoma
The US Food and Drug Administration (FDA) has granted a fast track designation to Sellas Life Sciences Group’s SLS009 for…
FDA
-
-
Pharma Technology Focus – Issue 73
Pharma Technology Focus is now available on all devices. Read it for free here. Genentech has signed a $1bn open-ended drug…
-
FDA recalls valsartan drug products after impurity detection
The US Food and Drug Administration (FDA) has announced a voluntary recall of multiple drug products containing valsartan as the…
